XRT secures new investors
Monday, 29 August, 2005
Unlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has secured new investment funds from a syndicate of UK investors including an undisclosed institutional group.
Total funds to be invested in XRT equate to approximately £1.5 million (AUD$3.8million) at a pre-money valuation of £7.1 million.
Melbourne based XRT is planning to relocate its business development activities to the UK and will use the funds for the recruitment of a UK-based senior management team and to execute its business plan.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
